Skip to content

Protocol Optimization in CT for the Quantification of BMD

Protocol-optimization in Computed Tomography for the Quantification of Bone Mineral Density (BMD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06305156
Enrollment
167
Registered
2024-03-12
Start date
2024-03-13
Completion date
2025-12-19
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Loss, Osteoporosis, Osteopenia

Brief summary

Bone mineral density is an important measurement to detect osteoporosis. The goal of this clinical trial is to compare bone mineral density measurements in CT examinations and DXA scans. The main question it aims to answer is: * How good is the measurement of bone mineral density in the new photon-counting CT in comparison to DXA * How can we optimize the CT scan for bone mineral density Participants will undergo: * Clinically indicated CT scan on day of inclusion * Study related DXA scan on a separate appointment

Interventions

DIAGNOSTIC_TESTBone Mineral Density quantification

In the first visit, participants receive clinically indicated CT scan, where bone mineral density will be derived. In a second, study related visit, participants will receive a DXA scan for bone mineral quantifications.

Sponsors

Hatem Alkadhi
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed Consent signed by the subject * Referral to a regular clinically indicated CT examination covering the lumbar area (e.g., Abdomen, Thorax + Abdomen, Neck + Thorax +Abdomen) * Informed written and oral consent (interpreter present in case of foreign language patients) * No contraindication to the clinically indicated CT examination

Exclusion criteria

* Patients \< 18 years * Pregnant women * Vulnerable subjects * Contraindications to the clinically indicated CT scan * Multiple Myeloma * Diffuse bone metastasis * Fixateur interne in the lumbar spine * Kyphoplasty in the lumbar spine * Enterally administrated contrast agent * Obtaining informed consent is not possible * Withdrawal of consent orally or in writing * Inability to follow the procedures of the investigation, e.g., due to language problems, psychological disorders, dementia, etc. of the subject * Immobility (patients confined to a wheelchair or to bed)

Design outcomes

Primary

MeasureTime frameDescription
Bone mineral density CTImmediately after CT scan of the participant.Bone mineral density derived from CT Scan
Bone mineral density Dual-energy x-ray absorptiometry (DXA)Immediately after DXA scan of the participant.Bone mineral density derived from DXA Scan

Secondary

MeasureTime frameDescription
Correlation between height and bone mineral density1 yearCorrelation analysis by means of linear regression and pearson correlation between height (in cm) and bone mineral density
Correlation between age and bone mineral density1 yearCorrelation analysis by means of linear regression and pearson correlation between age (in years) and bone mineral density
Correlation between body mass index (BMI) and bone mineral density1 yearCorrelation analysis by means of linear regression and pearson correlation between body mass index (BMI, in kg/m\^2) and bone mineral density
Correlation between weight and bone mineral density1 yearCorrelation analysis by means of linear regression and pearson correlation between weight and bone mineral density
Correlation between sex and bone mineral density1 yearCorrelation analysis by means of linear regression and pearson correlation between sex (male/female) and bone mineral density

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026